LINE PHARMACEUTICAL MEDICINAL

Brand	Owner (click to sort)	Address	Description
BLULINE	Bluline Laboratories, Inc.	St. Louis MO	LINE OF PHARMACEUTICAL AND MEDICINAL PREPARATIONS;FIRST USE AUG 7 1973, IN COMMERCE AUG 7 1973, OCT 1 1918, AS TO BLULINE.;BLUELINE;FIRST USE AUG 7 1973, IN COMMERCE AUG 7 1973, OCT 1 1918, AS TO BLULINE.;
BREON	BREON LABORATORIES INC.	NEW YORK N.Y.	LINE OF PHARMACEUTICAL AND MEDICINAL PRODUCTS;
ZAMBON	Zambon S.p.A.	Via Lillo del Duca 10 Bresso (MI) 20091 Italy	LINE OF PHARMACEUTICAL AND MEDICINAL PREPARATIONS FOR HUMAN AND VETERINARY USE;
ZAMBON Z	Zambon S.p.A.	Via Lillo del Duca 10 Bresso (MI) 20091 Italy	LINE OF PHARMACEUTICAL AND MEDICINAL PREPARATIONS FOR HUMAN AND VETERINARY USE;
	Where the owner name is not linked, that owner no longer owns the brand

Technical Examples

The present invention provides medicinal or pharmaceutical compositions and preparations for administration, which are useful as cytoprotective agents and a remedy for neurotrauma, comprising ginseng, its extract, ginseng components, metabolites thereof or salts thereof (for example, red ginseng powder or components thereof). More particularly, the present invention provides medicinal or pharmaceutical compositions for inhibiting apoptosis or apoptosis-like cell death, medicinal or pharmaceutical compositions for promoting the expression of a cell death-suppressing gene product Bcl-xL, or preparations for oral or intravenous administration, comprising ginseng, its extracts, ginseng components, metabolites thereof or salts thereof preferably at low concentrations. These medicinal or pharmaceutical compositions and/or preparations for administration are characterized by containing, as the active ingredient(s), ginseng, its extracts, ginseng components, metabolites thereof or salts thereof at low concentrations. These drugs are useful for therapy, prevention or treatment of brain and nervous diseases, heart diseases, etc.